<span style="font-family:Papyrus; font-size:2.0em;">**Pymaceuticals Inc.**</span> 
##<span style="color:blue"> Analyzing data from the recentmost animal study</span>
Pymaceuticals Inc., a burgeoning pharmaceutical company based in San Diego, specializes in anti-cancer pharmaceuticals. Recently, Pymaceuticals Inc. began screening for potential treatments for squamous cell carcinoma (SCC), a commonly occurring form of skin cancer.
In their most recent animal study, 250 mice identified with SCC tumor growth were treated through a variety of drug regimens. Over the course of 45 days, tumor development was observed and measured. The purpose of the study was to compare the performance of Pymaceuticals' drug of interest, Capomu-lin, versus the other treatment regimens. As tasked by the executive team, this report provides a top-level summary and the tables and figures needed for the technical report of the study. 
###<span style="color:green"> Business Problem study</span>
**_What are the meaningful insights regarding the performance of an anti-cancer drug Capomulin gained from a recent animal study?_**
